Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003517135 | SCV004292623 | uncertain significance | Hereditary pheochromocytoma-paraganglioma | 2022-11-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Cys140 amino acid residue in TMEM127. Other variant(s) that disrupt this residue have been observed in individuals with TMEM127-related conditions (PMID: 21156949), which suggests that this may be a clinically significant amino acid residue. Experimental studies have shown that this missense change affects TMEM127 function (PMID: 21156949). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 126971). This missense change has been observed in individuals with clinical features of TMEM127-related condition (PMID: 21156949, 28384794). This variant is present in population databases (rs121908828, gnomAD 0.006%). This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 140 of the TMEM127 protein (p.Cys140Tyr). |
Familial Cancer Clinic, |
RCV000114831 | SCV000148726 | likely pathogenic - adrenal bilateral pheochromocy | Pheochromocytoma | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |